Weight loss drugs could be a gamechanger for women with a common hormonal disorder

1. GLP-1 drugs show promise in treating PCOS symptoms but lack FDA endorsement. 2. Eli Lilly's Mounjaro may help PCOS patients, enhancing weight loss and hormone regulation. 3. Insurance coverage for GLP-1s is limited, affecting access for many patients. 4. Studies suggest GLP-1s improve insulin sensitivity, impacting PCOS treatment options. 5. Patient experiences indicate significant symptom relief, boosting demand for GLP-1s.